Article
Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression.
The Journal of biological chemistry - 18 Aug 2000
Valentine J E, Kalkhoven E, White R, Hoare S, Parker M G
Abstract excerpt
The estrogen receptor (ER) suppresses transcriptional activity of the RelA subunit of nuclear factor-kappaB in a hormone-dependent manner by a mechanism involving both the receptor DNA binding domain and ligand binding domain (LBD). In this study we examine the role of the ER LBD in mediating ligand-dependent RelA transrepression. Both ERalpha and ERbeta inhibit RelA in response to 17beta-estradiol but not in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
